Portuguese version of Parent-reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q): assessment of reliability and validityCristiana Ferreira email@example.com, Eva R. Gomes2, Joana Lopes3, Susana Cadinha3Show more: Authors information and Publication history
Centro Hospitalar Tamega e Sousa, Penafiel, Guilhufe, Portugal2
Department of Allergy and Clinical Immunology, Centro Hospitalar e Universitário do Porto, Porto, Portugal3
Department of Allergy and Clinical Immunology, Centro Hospitalar Vila Nova de Gaia/Espinho, EPE, Vila Nova de Gaia, Portugal
Published: 11 June 2021
Accepted: 11 June 2021
Received: 22 January 2021
Drug hypersensitivity in children impacts the quality of life of the patients and their caregivers. The parent-reported drug hypersensitivity quality of life questionnaire (P-DrHy-Q), the first disease-specific quality-of-life questionnaire for caregivers who have children with drug hypersensitivity, was recently developed. The aim of this study was to assess the validity and reliability of the portuguese version of the P-DrHy-Q. Methods.
A translation of the Parent-reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q) to the Portuguese population was performed, assessing its applicability in 74 caregivers from two allergy departments. The analyses included internal consistency (Cronbach's alpha) and test-retest reliability: 14 caregivers completed the P-DrHy-Q without any intervention one week after answering the first questionnaire. Results.
The 12-item scale assessed the mental health and social activity. The internal consistency of the scale was good (Cronbach's alpha = 0.884) and the test-retest associations were excelent (intra-class correlation coefficient = 0.985; p < 0.001). The mean value of the questionnaire was 37.01 (SD 18.57) with Mental Health being more affected than Social Activity. Employed caregivers had a significant higher score (p < 0.001). No other factor was statistically significant. Conclusions.
The Portuguese version of the P-DrHy-Q is valid for evaluating quality of life impairment in Portuguese caregivers of children with drug hypersensitivity. Its application might be relevant for future research and provide clinicians and researchers with a tool to define which psychosocial support is required to provide more comprehensive care in drug hypersensitivity.
Drug hypersensitivity; quality-of-life questionnaire for caregivers; validity and reliability; P-DrHy-Q.
Cite this article as:
Ferreira C, Gomes RE, Lopes J, Cadinha S. Portuguese version of Parent-reported Drug Hypersensitivity Quality of Life Questionnaire (P-DrHy-Q): assessment of reliability and validity. Eur Ann Allergy Clin Immunol. 2023;55(3):115-121. doi: 10.23822/EurAnnACI.1764-1489.221.